Georgia’s Senate Bill 220, the Putting Georgia’s Patients First Act, was signed on May 12, 2026, and took effect July 1. The law changes the statutory terminology from low-THC oil to medical cannabis and updates the state’s patient program. It is an enacted medical reform, not a recreational-legalization bill. [1][2]
The legislature’s post-session summary describes broader medical-cannabis authorization, revised possession rules, changes to qualifying conditions and revised registration-card renewal provisions. The enacted text also revises criminal-law exceptions and rules for consumption. Its protections are tied to compliance with the medical program; the legislation does not create an unrestricted right for anyone to possess or sell cannabis. [2][3]
The Georgia Access to Medical Cannabis Commission says registered patients and caregivers need a valid registry card. Its current FAQ lists authorized product forms including oils, tinctures, capsules and vaporizers, and describes a cumulative limit of 12,000 milligrams of THC. It also says smoking remains prohibited. The agency page contains detailed product and eligibility guidance, so readers should check that source before relying on a broad summary of the new law. [4]
Our position.
Georgia should publish implementation updates and ask patients about registration costs, product availability, and other barriers. Medical expansion should be assessed by whether eligible people can use the program.
Questions and next steps.
Ask state legislators and the commission to explain how they will evaluate patient access, publicize implementation changes and reduce avoidable administrative barriers.
Find your lawmakersThis is a dated policy explainer for public discussion. Laws, court orders and implementation dates can change. Check the official sources before relying on a legal detail. How we report and classify policy.